Axes 1–2 · Brand Index
Conditional score and coverage
Opacity share 27.3%. Brand results are not ordered when coverage bounds overlap. A brand-level sensitivity interval is undefined because the release preserves formulation-level intervals.
brand · release 2026-09-20
Kyo-Dophilus
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Formulations11
Conditional mean GIS63.22
Coverage72.7%
Axes 3–4
Measurement status and document panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Brand price aggregation
undefined: prices are retained at label-version level and are not averaged across formulations.
Brand profile
What this brand's labels look like as a set
- Named strains
- 13 distinct designations printed across the 4 published products of this brand, compared without regard to letter case: BB536, G9-1, KS-13, LAC-343, LCS-742, M-16V, M-63, MM-2, UAB IA-12, UAB LA-12, UALa-01, UALp-05 …
- Potency basis
- Potency is stated through expiry. 9 · The potency basis is not stated. 24 · counted across 33 organism rows on its labels, not across products
- Forms
- Capsule: 3 · Tablet or Pill: 1 · counted across the 4 of 4 products whose label states a form
- Observed prices
- 1 of 4 published products; cost per day $0.49 – $0.49
- Printed claims per label
- 2 on average across the 4 of 4 products whose label carries a parsed claim block. A printed claim is not evidence and enters no axis.
- Observed reformulations
- 16 label change(s) with a printed CFU or potency-basis change, counted only between two snapshots whose ingredient rows were both parsed
Products
Published product pages of this brand
| Product | Gut Index Score |
|---|---|
| Kyo-Dophilus Kyo-Dophilus | 65.47 |
| Kyo-Dophilus Kyo-Dophilus Pro+ Synbiotic Berry Smoothie | 65.69 |
| Kyo-Dophilus Max Probiotic | 49.86 |
| Kyo-Dophilus Multi 9 Probiotic | 49.53 |
Organisms
What this brand actually puts on its labels
Across its published products, 23 distinct organisms or ingredients are printed. The most frequent, with the number of published products carrying each:
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Supplier code network · Label designation changes
Tools: DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). Kyo-Dophilus. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/b/kyo-dophilus/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Kyo-Dophilus has 11 eligible SKUs and 11 formulation groups among labels in the NIH DSLD snapshot (Sep 2026).
11 / 11 formulation groups · NIH DSLD snapshot Sep 2026 · brand.skus · checked 2026-09-20T00:00:00Z · snapshot b7633f7324378 of 11 Kyo-Dophilus formulation groups have at least one printed strain designation (72.7%) in the NIH DSLD snapshot Sep 2026.
8 / 11 formulation groups · NIH DSLD snapshot Sep 2026 · brand.naming · checked 2026-09-20T00:00:00Z · snapshot b7633f7324373 of 11 Kyo-Dophilus formulation groups were scored using the available matching evidence (27.3%) in the NIH DSLD snapshot Sep 2026.
3 / 11 formulation groups · NIH DSLD snapshot Sep 2026 · brand.opacity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Kyo-Dophilus: conditional Brand Index 63.22 from 8 of 11 formulation groups with numeric Gut Index Scores (72.7%); unscored groups remain outside the mean. Window: NIH DSLD snapshot Sep 2026.
8 / 11 formulation groups · NIH DSLD snapshot Sep 2026 · brand.index · checked 2026-09-20T00:00:00Z · snapshot b7633f732437